Strategy and novel technology for treatment of Ebola virus disease: Research advances / 国际药学研究杂志
Journal of International Pharmaceutical Research
; (6): 69-75, 2015.
Article
em Zh
| WPRIM
| ID: wpr-845655
Biblioteca responsável:
WPRO
ABSTRACT
Ebola virus is a highly virulent pathogen causing severe hemorrhagic fever with a high fatality rate in humans. Although safe and effective therapeutics and treatment strategies or other medicinal agents in post-exposure therapeutics for the prevention of Ebola hemorrhagic are currently unavailable, a significant effort has been put forth to identify several promising candidates for post-exposure therapeutics and treatment of Ebola hemorrhagic fever. These potential strategies and novel technology include monoclonal antibody cocktail, polymerase inhibitors and lipid nanoparticle/small interfering RNA. This article summarizes recent advances in therapeutics and treatment strategies and novel technology in Ebola virus post-infection in small animals and non-human primates.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of International Pharmaceutical Research
Ano de publicação:
2015
Tipo de documento:
Article